MECP2 and hepatocellular carcinoma: From the gain‐ and loss‐of‐function of MeCP2 and HOXD3, MeCP2 promoted the expression of HOXD3 via the HB‐EGF cell signaling pathway to induce migration, invasion, and angiogenesis in HCC.